Does neurotropin-3 have a therapeutic implication in major depression?

International Journal of Neuroscience

Volumn 118, Issue 11, 2008, Pages 1515-1522

  Pae, Chi Un ^a,b,d,e   Marks, David M ^b   Han, Changsu ^b,c   Patkar, Ashwin A ^b   Steffens, David ^b  

^a The Catholic University of Korea College of Medicine   (South Korea)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Korea University College of Medicine   (South Korea)

^d The Catholic University of Korea   (South Korea)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Depression; Neurotropin 3; Therapeutic implication

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MOOD STABILIZER; NEUROTROPIN; NEUROTROPIN 3; NORADRENALIN; PROTEIN KINASE FER; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CELL SURVIVAL; CLINICAL FEATURE; DRUG INHIBITION; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR DEPRESSION; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANIMALS; ANTIDEPRESSIVE AGENTS; BIOGENIC MONOAMINES; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL SURVIVAL; DEPRESSIVE DISORDER; HUMANS; NEURONAL PLASTICITY; NEUROPROTECTIVE AGENTS; NEUROTROPHIN 3;

EID: 53949087364     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.1080/00207450802174589     Document Type: Article

References (30)

1. Bothwell, M. (1995). Functional interactions of neurotrophins and neurotrophin receptors. Annual Review of Neuroscience, 18, 223-253.
2. Bourin, M., David, D. J., Jolliet, P., & Gardier, A. (2002). Mechanism of action of antidepressants and therapeutic perspectives. Therapie, 57(4), 385-396.
3. Cavanaugh, J. E., Ham, J., Hetman, M., Poser, S., Yan, C., & Xia, Z. (2001). Differential regulation of mitogen-activated protein kinases ERK1/2 and ERK5 by neurotrophins, neuronal activity, and cAMP in neurons. Journal of Neuroscience, 21(2), 434-443.
4. Celada, P., Siuciak, J. A., Tran, T. M., Altar, C. A., & Tepper, J. M. (1996). Local infusion of brain-derived neurotrophic factor modifies the firing pattern of dorsal raphe serotonergic neurons. Brain Research, 712(2), 293-298.
5. Crown, W. H., Finkelstein, S., Berndt, E. R., Ling, D., Poret, A. W., Rush, A. J., et al. (2002). The impact of treatment-resistant depression on health care utilization and costs. The Journal of Clinical Psychiatry, 63(11), 963-971.
6. Duman, R. S. (2002). Pathophysiology of depression: The concept of synaptic plasticity. Euopeanr Psychiatry, 17(Suppl. 3), S306-S310.
7. Faure, J., Uys, J. D., Marais, L., Stein, D. J., & Daniels, W. M. (2006). Early maternal separation followed by later stressors leads to dysregulation of the HPA-axis and increases in hippocampal NGF and NT-3 levels in a rat model. Metabolic Brain Disease, 21(2-3), 181-188.
8. Fava, M., Thase, M. E., & DeBattista, C. (2005). A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness. The Journal of Clinical Psychiatry, 66(1), 85-93.
9. Freeman, A. Y., & Pierce, R. C. (2002). Neutralization of neutrophin-3 in the ventral tegmental area or nucleus accumbens differentially modulates cocaine-induced behavioral plasticity in rats. Synapse, 46(2), 57-65.
10. Fumagalli, F., Molteni, R., Calabrese, F., Frasca, A., Racagni, G., & Riva, M. A. (2005). Chronic fluoxetine administration inhibits extracellular signal-regulated kinase 1/2 phosphorylation in rat brain. Journal of Neurochemistry, 93(6), 1551-1560.
11. Gratacos, M., Soria, V., Urretavizcaya, M., Gonzalez, J. R., Crespo, J. M., Bayes, M., et al. (2007). A brain-derived neurotrophic factor (BDNF) haplotype is associated with antidepressant treatment outcome in mood disorders. Pharmacogenomics Journal, 8(2), 101-112.
12. Hoshaw, B. A., Malberg, J. E., & Lucki, I. (2005). Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects. Brain Research, 1037(1-2), 204-208.
13. Huang, T. L., Lee, C. T., & Liu, Y. L. (2008). Serum brain-derived neurotrophic factor levels in patients with major depression: Effects of antidepressants. Journal of Psychiatric Research, 42(7), 521-525.
14. Kempermann, G., & Kronenberg, G. (2003). Depressed new neurons - Adult hippocampal neurogenesis and a cellular plasticity hypothesis of major depression. Biological Psychiatry, 54(5), 499-503.
15. Kushikata, T., Kubota, T., Fang, J., & Krueger, J. M. (2003). Neurotrophins 3 and 4 enhance non-rapid eye movement sleep in rabbits. Neuroscience Letters, 346(3), 161-164.
16. Mamounas, L. A., Blue, M. E., Siuciak, J. A., & Altar, C. A. (1995). Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. Journal of Neuroscience, 15(12), 7929-7939.
17. Martin-Iverson, M. T., Todd, K. G., & Altar, C. A. (1994). Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors: Interactions with amphetamine. Journal of Neuroscience, 14(3 Pt. 1), 1262-1270.
18. Nielsen, D. M. (2006). Corticotropin-releasing factor type-1 receptor antagonists: the next class of antidepressants? Life Sciences, 78(9), 909-919.
19. Paul, J., Gottmann, K., & Lessmann, V. (2001). NT-3 regulates BDNF-induced modulation of synaptic transmission in cultured hippocampal neurons. Neuroreport, 12(12), 2635-2639.
20. Pierce, R. C., Pierce-Bancroft, A. F., & Prasad, B. M. (1999). Neurotrophin-3 contributes to the initiation of behavioral sensitization to cocaine by activating the Ras/Mitogen-activated protein kinase signal transduction cascade. Journal of Neuroscience, 19(19), 8685-8695.
21. Saarelainen, T., Hendolin, P., Lucas, G., Koponen, E., Sairanen, M., MacDonald, E., et al. (2003). Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. Journal of Neuroscience, 23(1), 349-357.
22. Sandi, C., & Bisaz, R. (2007). A model for the involvement of neural cell adhesion molecules in stress-related mood disorders. Neuroendocrinology, 85(3), 158-176.
23. Schutte, A., Yan, Q., Mestres, P., & Giehl, K. M. (2000). The endogenous survival promotion of axotomized rat corticospinal neurons by brain-derived neurotrophic factor is mediated via paracrine, rather than autocrine mechanisms. Neuroscience Letters, 290(3), 185-188.
24. Sheline, Y. I., Wang, P. W., Gado, M. H., Csernansky, J. G., & Vannier, M. W. (1996). Hippocampal atrophy in recurrent major depression. Proceedings of the National Academy of Sciences of the United States of America, 93(9), 3908-3913.
25. Shimazu, K., Zhao, M., Sakata, K., Akbarian, S., Bates, B., Jaenisch, R., et al. (2006). NT-3 facilitates hippocampal plasticity and learning and memory by regulating neurogenesis. Learning & Memory, 13(3), 307-315.
26. Sieber-Blum, M.,&Ren, Z. (2000). Norepinephrine transporter expression and function in noradrenergic cell differentiation. Molecular and Cellular Biochemistry, 212(1-2), 61-70.
27. Siuciak, J. A., Boylan, C., Fritsche, M., Altar, C. A., & Lindsay, R. M. (1996). BDNF increases monoaminergic activity in rat brain following intracerebroventricular or intraparenchymal administration. Brain Research, 710(1-2), 11-20.
28. Smith, M. A., Makino, S., Altemus, M., Michelson, D., Hong, S. K., Kvetnansky, R., et al. (1995). Stress and antidepressants differentially regulate neurotrophin 3 mRNA expression in the locus coeruleus. Proceedings of the National Academy of Sciences of the United States of America, 92(19), 8788-8792.
29. Tardito, D., Perez, J., Tiraboschi, E., Musazzi, L., Racagni, G., & Popoli, M. (2006). Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview. Pharmacological Reviews, 58(1), 115-134.
30. Walz, J. C., Frey, B. N., Andreazza, A. C., Cereser, K. M., Cacilhas, A. A., Valvassori, S. S., et al. (in press). Effects of lithium and valproate on serum and hippocampal neurotrophin-3 levels in an animal model of mania. Journal of Psychiatric Research.